Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2025

Sep 9, 2025

30786_dirs_2025-09-09_2dc69945-53cc-4789-8d35-a4f41610ba5e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIO.B)
CIK: 0000012208
Period of Report: 2025-09-05

Reporting Person: ENGELHARDT EVA ANETTE (EVP, President, CDG)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-09-06 Bio-Rad A Common Stock M 1152 Acquired 1309 Direct
2025-09-06 Bio-Rad A Common Stock F 413 $295.43 Disposed 896 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-09-05 Restricted Stock Units $0 A 4110 Acquired Bio-Rad A Common Stock (4110) Direct
2025-09-06 Restricted Stock Units $0 M 1152 Disposed Bio-Rad A Common Stock (1152) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.